ArticleInternational urology and nephrology2023

Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia.

Jae Duck Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.